Chinook Therapeutics Inc.

NASDAQ: KDNY · Real-Time Price · USD
40.39
0.09 (0.22%)
At close: Aug 10, 2023, 10:00 PM

Chinook Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-187.87M -102.94M
Depreciation & Amortization
5.1M 4.75M
Stock-Based Compensation
20.05M 12.79M
Other Working Capital
8.89M -95K
Other Non-Cash Items
21.65M -13.57M
Deferred Income Tax
4.34M 2.09M
Change in Working Capital
19.24M -5.86M
Operating Cash Flow
-117.48M -102.74M
Capital Expenditures
-1.65M -1.88M
Cash Acquisitions
99.99M n/a
Purchase of Investments
-299.18M -232.34M
Sales Maturities Of Investments
200.84M 121.31M
Other Investing Acitivies
-99.99M 267K
Investing Cash Flow
-99.99M -112.64M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
151.43M 209.52M
Financial Cash Flow
151.43M 209.52M
Net Cash Flow
-66.29M -5.7M
Free Cash Flow
-119.13M -104.62M